IndiaInfoline » Markets » GLENMARK

Glenmark Pharmaceuticals Ltd - Share Price

GLENMARK

Open

480.00

Prev. Close

479.70

Turnover (lac.)

5,660

Day's High

485.75

Day's Low

479.10

52 Week's High

573.05

52 Week's Low

161.65

Book Value

499

Face Value

1

Mkt Cap (Cr.)

13,685

P/E

8.89

EPS

53.95

Divi. Yield

0.52

Glenmark Pharmaceuticals LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Glenmark Pharmaceuticals LtdNews & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd547.7545.38130,763.76724.810.733,207.24106.10
Divis Laboratories Ltd3,681.6054.9696,627.91513.300.441,713.78313.47
Dr Reddys Laboratories Ltd4,888.0032.8480,637.51481.000.523,333.60979.45
Cipla Ltd760.7027.2661,140.71745.640.533,711.03233.61
Aurobindo Pharma Ltd894.4019.5852,092.87801.540.344,425.43246.88

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Glenmark Pharmaceuticals LtdSummary & Reports

Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in var... More

Registered Office

B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road,Mumbai, Maharashtra,400026

Tell. : +91-22-40189999
Website : http://www.glenmarkpharma.com
Email : complianceofficer@glenmarkpharma.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com

View

- <

Reco. Price

Dec 01,2020 10:18 AM

Target Price

Target Returns:

0.00%

Result Express

Glenmark Pharmaceuticals Ltd's Q2FY19 consolidated net profit rises 15.27% yoy to Rs246.82cr : Beats Estimates

Dec 03, 2020 01:46 PM

The company’s consolidated revenue stood at Rs2,581.33cr, up 14.39% yoy and 19.2% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    06 Nov 2020

    Annc. Date

    27 Oct 2020

    GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Comp... More

  • Purpose

    AGM

    Exp. Date

    29 Sep 2020

    Annc. Date

    31 Aug 2020

    AGM 29/09/2020Further to our letter dated August 31, 2020, enclosed please find herewith the Notice ... More

  • Purpose

    Dividend

    Annc. Date

    26 Jun 2020

    Effective. Date

    17 Sep 2020

    Divi. Type

    Final

    Divi.(%)

    250

    Divi. Amt.

    2.5

    Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meet... More